LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Clinical trials for LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Timing is everything: new trial seeks best day for immunotherapy in nose cancer
Disease control Not yet recruitingThis study tests whether giving the immunotherapy drug toripalimab on day 1, 5, or 9 of chemotherapy cycles improves tumor shrinkage in people with advanced nasopharyngeal cancer. About 198 adults will receive 3 cycles of chemo plus toripalimab, followed by standard chemoradiatio…
Matched conditions: LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
New drug combo may let some cancer patients skip harsh chemo
Disease control Not yet recruitingThis study tests whether adding the drug serplulimab to standard induction chemotherapy can allow patients with advanced nasopharyngeal cancer to safely skip the intense concurrent chemotherapy that usually follows. The trial will enroll 456 adults aged 18-65 with previously untr…
Matched conditions: LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 22, 2026 13:50 UTC